Passive all-weather home windows, able to selectively transmitting seen and infrared photo voltaic radiation, may assist in bringing down fossil-fuel vitality consumption globally by lowering the carbon footprint of typical air-conditioning methods for buildings and motor automobiles. Right here, we report on designing metal-insulator-metal thin-films for utility in passive home windows, optimized for various weather conditions. We analyze designs comprising completely different noble metals in addition to their comparatively cheap options. By discovering an optimum alternative of supplies and thicknesses of the metallic and dielectric layers, our lithography-free easy design can present all-weather options for passive home windows with desired seen and infrared transmission/blocking functionality.
Obtained theoretical outcomes agree properly with full-wave simulations. Thus, our proposed designs allow growing low-cost, ultra-thin (thickness: 47-85 nm), polarization-independent, angle-insensitive (as much as 83 deg), and large-area-compatible passive home windows with improved solar-radiation management for various climate/weather conditions. The figure-of-merit calculation reveals that the comparatively cheap metals utilized in our passive glasses can outperform industry-standard industrial glasses and beforehand reported infrared-blocking plasmonic glasses. Setting up a van der Waals heterostructure is a sensible solution to promote the conversion effectivity of photo voltaic vitality.
Right here, we display the environment friendly efficiency of a GeSe/AsP heterostructure in photo voltaic vitality cells primarily based on the first-principles calculations. The digital properties, optical absorption, and optoelectronic properties are calculated to guage the effectivity of the newly designed heterostructure. The outcomes point out that the GeSe/AsP heterostructure possesses a type-II band alignment with an oblique bandgap of 1.10 eV, which enormously promotes the efficient separation of photogenerated carriers. In addition to, an intrinsic electrical discipline is shaped within the route from the AsP to GeSe monolayer, which is helpful to stop the recombination of the photogenerated electron-hole pair.
Concurrently, a powerful optical absorption is noticed within the seen mild vary. The expected energy conversion effectivity (PCE) of the GeSe/AsP heterostructure is 16.0% and may b We assumed photo voltaic publicity profiles primarily based on each day habits for an implanted photo voltaic cell. The output energy was calculated for pores and skin varieties VI and I/II. In comparison with the CSS-BPW, the manufacturing of ingesting water was elevated by 68.57% when utilizing the reflective glass mirrors and 48.57% when utilizing the reflective aluminium foil sheet.
Grain Measurement Influences Activation Power and Migration Pathways in MAPbBr 3 Perovskite Photo voltaic Cells
Ion migration in perovskite layers can considerably scale back the long-term stability of the units. Whereas perovskite composition engineering has confirmed an attention-grabbing device to mitigate ion migration, many optoelectronic units require a selected bandgap and thus require a selected perovskite composition. Right here, we have a look at the impact of grain dimension to mitigate ion migration. We discover that in MAPbBr3 photo voltaic cells ready with grain sizes various from 2 to 11 μm the activation vitality for bromide ion migration will increase from 0.17 to 0.28 eV.
Furthermore, we observe the looks of a second bromide ion migration pathway for the units with largest grain dimension, which we attribute to ion migration mediated by the majority of the perovskite, versus ion migration mediated by the grain boundaries. Collectively, these outcomes counsel the helpful nature of grain engineering for discount of ion migration in perovskite photo voltaic cells. Many researchers are searching for easy and profitable options to extend the output from the photo voltaic distiller. On this analysis work, reflective mirrors and reflective aluminium foil sheet had been mounted on interior surfaces of the single-slope photo voltaic distiller, resulting in extra water manufacturing.
The presence of reflective mirrors and reflective aluminium foil sheet on interior surfaces of the photo voltaic distillate permits the reflection of photo voltaic radiation falling contained in the basin. Experiments had been carried out on three stills: the primary distiller is typical photo voltaic nonetheless with black painted partitions (CSS-BPW); the second distiller is typical photo voltaic nonetheless with reflective aluminium foil sheet partitions (CSS-RAFW); and the third distiller is typical photo voltaic nonetheless with reflective glass mirror partitions (CSS-RGMW). The utmost whole ingesting water productions from the CSS, CSS-RAFW and the CSS-RGMW are 3.41, 5.1 and 5.54 kg/m2, respectively.
The potential of city distributed photo voltaic vitality in transition economies: The case of Beirut metropolis
On this paper, utilizing Lebanon’s capital, Beirut, as a case research, a strategy is proposed to evaluate the potential for photo voltaic photovoltaics (PV) in city areas incorporating each financial and non-economic components. Using a wealthy spatial dataset of photo voltaic irradiation augmented with electrical energy payments on the constructing stage, the fee and profit of putting in rooftop PV methods for every constructing is estimated. Moreover, incentives and obstacles for adopting these methods are investigated utilizing a probabilistic alternative mannequin. The outcomes present that Beirut metropolis has a possible for distributed rooftop photo voltaic PV to be between 195 and 295 MWp.
Nevertheless, adoption charges are low at 0.49% and 1.23% for residential and industrial buildings, respectively, reflecting the limitation of economic incentives alone to advertise the deployment of distributed renewable vitality methods in transition economies. The influence of various incentive coverage devices and the function of photo voltaic PV in as we speak’s financial disaster in Lebanon is analyzed. The most important influence was achieved by way of eradicating (or decreasing) electrical energy tariff subsidy, though this feature stays extremely constrained by political calculus.
 Antibody) Nucleolar Protein 3 (NOL3) Antibody |
|
20-abx210877 |
Abbexa |
|
|
|
|
Nucleolar Protein 3 (NOL3) Antibody |
|
abx331497-100ul |
Abbexa |
100 ul |
EUR 425 |
|
|
 Protein) Nucleolar Protein 3 (NOL3) Protein |
|
20-abx260930 |
Abbexa |
-
EUR 3418.00
-
EUR 328.00
-
EUR 230.00
|
|
|
|
 Antibody (HRP)) Nucleolar Protein 3 (NOL3) Antibody (HRP) |
|
20-abx304651 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody (FITC)) Nucleolar Protein 3 (NOL3) Antibody (FITC) |
|
20-abx304652 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody (Biotin)) Nucleolar Protein 3 (NOL3) Antibody (Biotin) |
|
20-abx304653 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
) Human Nucleolar protein 3 (NOL3) |
|
1-CSB-EP015921HU |
Cusabio |
-
EUR 380.00
-
EUR 214.00
-
EUR 1309.00
-
EUR 560.00
-
EUR 873.00
-
EUR 262.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
|
|
Description: Recombinant Human Nucleolar protein 3(NOL3) expressed in E.coli |
 NOL3 Nucleolar Protein 3 Human Recombinant Protein |
|
PROTO60936 |
BosterBio |
Regular: 20ug |
EUR 317 |
|
Description: NOL3 Human Recombinant produced in E. coli is a single polypeptide chain containing 231 amino acids (1-208) and having a molecular mass of 25.0 kDa.;NOL3 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
 Nucleolar Helicase antibody |
|
10R-2459 |
Fitzgerald |
5 mL |
EUR 405 |
|
Description: Mouse monoclonal Nucleolar Helicase antibody |
Nucleolar Helicase antibody |
|
10R-2491 |
Fitzgerald |
250 uL |
EUR 478 |
|
Description: Mouse monoclonal Nucleolar Helicase antibody |
 Antibody) Nucleolar Protein 6 (NOL6) Antibody |
|
20-abx301690 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody) Nucleolar Protein 10 (NOL10) Antibody |
|
20-abx302728 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
Nucleolar Protein 10 (NOL10) Antibody |
|
abx122120-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
 Antibody) Nucleolar Protein 9 (NOL9) Antibody |
|
abx122121-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
 Antibody) Nucleolar Protein 16 (NOP16) Antibody |
|
abx122144-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
Nucleolar Protein 9 (NOL9) Antibody |
|
20-abx124786 |
Abbexa |
|
|
|
|
 Antibody) Nucleolar Protein 12 (NOL12) Antibody |
|
20-abx114217 |
Abbexa |
|
|
|
|
 Antibody) Nucleolar Protein 8 (NOL8) Antibody |
|
20-abx114219 |
Abbexa |
|
|
|
|
) Nucleolar protein 58 Antibody (Biotin) |
|
20-abx105733 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
) Nucleolar protein 58 Antibody (FITC) |
|
20-abx107151 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
) Nucleolar protein 58 Antibody (HRP) |
|
20-abx108572 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody) Nucleolar Protein 58 (NOL58) Antibody |
|
20-abx110057 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
Nucleolar Protein 9 (NOL9) Antibody |
|
abx034569-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Nucleolar Protein 9 (NOL9) Antibody |
|
abx034569-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
 Antibody) Nucleolar Protein 4 (NOL4) Antibody |
|
abx029414-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Nucleolar Protein 4 (NOL4) Antibody |
|
abx029414-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Nucleolar Protein 16 (NOP16) Antibody |
|
abx030640-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Nucleolar Protein 16 (NOP16) Antibody |
|
abx030640-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Nucleolar Protein 4 (NOL4) Antibody |
|
20-abx217203 |
Abbexa |
|
|
|
|
Nucleolar Protein 8 (NOL8) Antibody |
|
20-abx217204 |
Abbexa |
|
|
|
|
 Antibody) Nucleolar Protein 11 (NOL11) Antibody |
|
20-abx217281 |
Abbexa |
|
|
|
|
Nucleolar Protein 12 (NOL12) Antibody |
|
20-abx217282 |
Abbexa |
|
|
|
|
 Antibody) Nucleolar Protein 14 (NOL14) Antibody |
|
20-abx217283 |
Abbexa |
|
|
|
|
 Antibody) Nucleolar Protein 7 (NOL7) Antibody |
|
20-abx217284 |
Abbexa |
|
|
|
|
Nucleolar Protein 12 (NOL12) Antibody |
|
abx235783-100ug |
Abbexa |
100 ug |
EUR 509 |
|
|
Nucleolar Protein 4 (NOL4) Antibody |
|
abx235785-100ug |
Abbexa |
100 ug |
EUR 481 |
|
|
Nucleolar Protein 6 (NOL6) Antibody |
|
abx235786-100ug |
Abbexa |
100 ug |
EUR 481 |
|
|
Nucleolar Protein 6 (NOL6) Antibody |
|
abx235787-100ug |
Abbexa |
100 ug |
EUR 509 |
|
|
Nucleolar Protein 8 (NOL8) Antibody |
|
abx235788-100ug |
Abbexa |
100 ug |
EUR 509 |
|
|
Nucleolar Protein 9 (NOL9) Antibody |
|
abx235789-100ug |
Abbexa |
100 ug |
EUR 551 |
|
|
 Antibody) NOP2 Nucleolar Protein (NOP2) Antibody |
|
abx235794-100ug |
Abbexa |
100 ug |
EUR 481 |
|
|
Nucleolar Protein 8 (NOL8) Antibody |
|
20-abx141132 |
Abbexa |
-
EUR 356.00
-
EUR 537.00
-
EUR 217.00
|
|
|
|
Nucleolar Protein 9 (NOL9) Antibody |
|
20-abx211330 |
Abbexa |
|
|
|
|
 Nucleolar protein 58 Polyclonal Antibody |
|
42696-100ul |
SAB |
100ul |
EUR 333 |
Nucleolar Protein 8 (NOL8) Antibody |
|
20-abx324504 |
Abbexa |
|
|
|
|
Nucleolar Protein 10 (NOL10) Antibody |
|
20-abx324613 |
Abbexa |
|
|
|
|
) Recombinant Human Nucleolar Protein 3/NOL3 (His) |
|
C153-10ug |
Novoprotein |
10ug |
EUR 156 |
|
Description: Supplied as a 0.2 μm filtered solution of 25mM TrisHCl, 1mM DTT, 1mM EDTA, 2mM β-ME, 20% Glycerol, pH 7.5. |
Recombinant Human Nucleolar Protein 3/NOL3 (His) |
|
C153-1mg |
Novoprotein |
1mg |
EUR 2283 |
|
Description: Supplied as a 0.2 μm filtered solution of 25mM TrisHCl, 1mM DTT, 1mM EDTA, 2mM β-ME, 20% Glycerol, pH 7.5. |
Recombinant Human Nucleolar Protein 3/NOL3 (His) |
|
C153-500ug |
Novoprotein |
500ug |
EUR 1613 |
|
Description: Supplied as a 0.2 μm filtered solution of 25mM TrisHCl, 1mM DTT, 1mM EDTA, 2mM β-ME, 20% Glycerol, pH 7.5. |
Recombinant Human Nucleolar Protein 3/NOL3 (His) |
|
C153-50ug |
Novoprotein |
50ug |
EUR 369 |
|
Description: Supplied as a 0.2 μm filtered solution of 25mM TrisHCl, 1mM DTT, 1mM EDTA, 2mM β-ME, 20% Glycerol, pH 7.5. |
 ELISA Kit) Human Nucleolar Protein 3 (NOL3) ELISA Kit |
|
abx381839-96tests |
Abbexa |
96 tests |
EUR 911 |
|
|
 anti-Nucleolar protein 14 |
|
YF-PA15741 |
Abfrontier |
50 ug |
EUR 363 |
|
Description: Mouse polyclonal to Nucleolar protein 14 |
 (GNL3) Antibody) Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx112902 |
Abbexa |
|
|
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx004951 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx031127-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx031127-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx015873-100ul |
Abbexa |
100 ul |
EUR 411 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx015874-100ug |
Abbexa |
100 ug |
EUR 411 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx432758-200ul |
Abbexa |
200 ul |
EUR 384 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
abx432759-200ul |
Abbexa |
200 ul |
EUR 384 |
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx320407 |
Abbexa |
|
|
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx320408 |
Abbexa |
|
|
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx211238 |
Abbexa |
|
|
|
|
Guanine Nucleotide Binding Protein Like 3 (Nucleolar) (GNL3) Antibody |
|
20-abx211323 |
Abbexa |
|
|
|
|
 Antibody) EMG1 Nucleolar Protein Homolog (EMG1) Antibody |
|
abx122814-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
EMG1 Nucleolar Protein Homolog (EMG1) Antibody |
|
20-abx112282 |
Abbexa |
|
|
|
|
 Antibody) Nop2 Nucleolar Protein Homolog (Yeast) Antibody |
|
20-abx114152 |
Abbexa |
|
|
|
|
EMG1 Nucleolar Protein Homolog (EMG1) Antibody |
|
20-abx003301 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
|
|
 Antibody (HRP)) Nucleolar Protein 6 (NOL6) Antibody (HRP) |
|
20-abx311187 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody (FITC)) Nucleolar Protein 6 (NOL6) Antibody (FITC) |
|
20-abx311188 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
 Antibody (Biotin)) Nucleolar Protein 6 (NOL6) Antibody (Biotin) |
|
20-abx311189 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
-
100 ug
-
1 mg
-
200 ug
-
20 ug
-
50 ug
|
|
|
EMG1 Nucleolar Protein Homolog (EMG1) Antibody |
|
abx232754-100ug |
Abbexa |
100 ug |
EUR 481 |
|
|
 Nucleolar protein 58 Polyclonal Conjugated Antibody |
|
C42696 |
SAB |
100ul |
EUR 397 |
 Recombinant Human MMP-3 Protein |
|
PROTP08254-3 |
BosterBio |
10ug |
EUR 317 |
|
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-3 degrades fibronectin, laminin, collagens III, IV, and X, and cartilage proteoglycans. Recombinant human MMP-3 is a 42.8 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (378 amino acids). |
 Antibody) Nucleolar / Nucleoli(NM95) Antibody |
|
BNCA0095-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), APC conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCAP0095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCAP0095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC810095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF680R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC810095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF680R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC880095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF488A conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC880095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF488A conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCB0095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Biotin conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCB0095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Biotin conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC550095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF555 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC550095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF555 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC470095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF647 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC470095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF647 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC940095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF594 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC940095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF594 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCP0095-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), PerCP conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCR0095-250 |
Biotium |
250uL |
EUR 383 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), RPE conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC040095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF405S conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC040095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF405S conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC050095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF405M conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC050095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF405M conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNUB0095-100 |
Biotium |
100uL |
EUR 209 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Concentration: 0.2mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNUB0095-500 |
Biotium |
500uL |
EUR 458 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Concentration: 0.2mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNUM0095-50 |
Biotium |
50uL |
EUR 395 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), 1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC680095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF568 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC680095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF568 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC700095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF770 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC700095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF770 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC800095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF680 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC800095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF680 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC400095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF640R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC400095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF640R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC610095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF660R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC610095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF660R conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC430095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF543 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNC430095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), CF543 conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCH0095-100 |
Biotium |
100uL |
EUR 199 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Nucleolar / Nucleoli(NM95) Antibody |
|
BNCH0095-500 |
Biotium |
500uL |
EUR 544 |
|
Description: Primary antibody against Nucleolar / Nucleoli(NM95), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
 IL-3 Interleukin-3 Human Recombinant Protein, His Tag |
|
PROTP08700-3 |
BosterBio |
Regular: 50ug |
EUR 317 |
|
Description: Interleukin-3 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 154 amino acids fragment (20-152) and having a total molecular mass of 17.3kDa and fused with a 20 aa N-terminal His tag. ;The IL3 His is purified by proprietary chromatographic techniques. |
 Anti-14-3-3 alpha + beta Rabbit Monoclonal Antibody |
|
M02431-3 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal 14-3-3 alpha + beta Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
) Recombinant Human Nucleolar Protein 3/NOL3 (N-GST) |
|
C197-10ug |
Novoprotein |
10ug |
EUR 156 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl,350mM NaCl,1mM DTT,pH 8.0. |
Recombinant Human Nucleolar Protein 3/NOL3 (N-GST) |
|
C197-1mg |
Novoprotein |
1mg |
EUR 2283 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl,350mM NaCl,1mM DTT,pH 8.0. |
Recombinant Human Nucleolar Protein 3/NOL3 (N-GST) |
|
C197-500ug |
Novoprotein |
500ug |
EUR 1613 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl,350mM NaCl,1mM DTT,pH 8.0. |
Recombinant Human Nucleolar Protein 3/NOL3 (N-GST) |
|
C197-50ug |
Novoprotein |
50ug |
EUR 369 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl,350mM NaCl,1mM DTT,pH 8.0. |
We argue that the Lebanese authorities ought to fast-track and implement the required authorized framework to facilitate and incentivize distributed energy era from renewable sources to advertise each inexperienced vitality and its monetary resilience. The proposed modeling framework along with the outcomes obtained on this research could have essential implications for vitality coverage makers in Lebanon and different transition economies.
ELISA Kit )
